Skip to content

Targeted broadband UV-B phototherapy in pityriasis alba

Use of targeted broad band UV-B in the treatment of pityriasis alba over the face- A randomized controlled pilot study

Status
Recruiting
Phases
Phase 1Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2017/12/010882
Enrollment
50
Registered
2017-12-14
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Children suffering from pityriasis alba

Interventions

Intervention1: Broad band UVB targeted phototherapy: Total 50 children suffering from pityriasis alba will be randomised into 2 groups of 25 each. In the study group, lesions treated using the broad b

Sponsors

IADVL
Lead Sponsor
Amrita Institute of Medical Sciences and Research Centre
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: Pityriasis alba clinically diagnosed by at least two dermatologists, lesions only over the face,duration of lesions less than 1 month, fungal scraping/ KOH smear negative

Exclusion criteria

Exclusion criteria: History of using topical steroids or calcineurin inhibitors on the lesions, any other significant skin or systemic illness which in the investigators opinion can affect the treatment plan and /or response to treatment

Design outcomes

Primary

MeasureTime frame
Improvement in scaling, hypopigmentation, and pruritus in a 4-point score at the end of 12 weeksTimepoint: Baseline and weeks 3,6,12

Secondary

MeasureTime frame
Worsening of the clinical condition or any other complicationsTimepoint: anytime during the study

Countries

India

Contacts

Public ContactDr Soumya Jagadeesan

Amrita Institute of Medical Sciences and Research Centre

soumya19601@aims.amrita.edu04844008590

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026